Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 11 July 2020)

 

Measuring vaccine effectiveness against persistent HPV infections: a comparison of different statistical approaches
Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approac…
Authors: R. Donken, J. Hoes, M. J. Knol, G. S. Ogilvie, S. Dobson, A. J. King, J. Singer, P. J. Woestenberg, J. A. Bogaards, C. J. L. M. Meijer and H. E. de Melker
Citation: BMC Infectious Diseases 2020 20:482
Content type: Research article
Published on: 8 July 2020